These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The MTA-rip it up and start again? Ku K; Henderson J Nat Biotechnol; 2007 Jul; 25(7):721-4. PubMed ID: 17621290 [No Abstract] [Full Text] [Related]
3. KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies. Bouchard RA Health Law J; 2007; 15():247-94. PubMed ID: 19702185 [No Abstract] [Full Text] [Related]
4. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
5. Access to tangible research materials in biomedical research: conditions of access and their effect on research. Monotti AL J Law Med; 2006 Aug; 14(1):86-101. PubMed ID: 16937783 [TBL] [Abstract][Full Text] [Related]
6. US trade rules seek to balance health and patent protection. Wadman M; Cherry M Nature; 1999 Dec; 402(6762):567-8. PubMed ID: 10604448 [No Abstract] [Full Text] [Related]
7. The roles of patents and research and development incentives in biopharmaceutical innovation. Grabowski HG; DiMasi JA; Long G Health Aff (Millwood); 2015 Feb; 34(2):302-10. PubMed ID: 25646111 [TBL] [Abstract][Full Text] [Related]
8. International panel considers global patent system needs reassessment. Ashraf H Lancet; 2002 Sep; 360(9336):858. PubMed ID: 12243929 [No Abstract] [Full Text] [Related]
9. Science and the law. Working through the patent problem. Walsh JP; Cohen WM; Arora A Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928 [No Abstract] [Full Text] [Related]
10. Patent pending. The challenges of bringing an invention to market. Goldman PM Minn Med; 1999 Sep; 82(9):29-31. PubMed ID: 10510615 [No Abstract] [Full Text] [Related]
11. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
12. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries. Spectar JM Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914 [No Abstract] [Full Text] [Related]
13. Enforcing pharmaceutical and biotech patent rights in China. Zhang YP; Deng MM Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760 [No Abstract] [Full Text] [Related]
14. USA-Morocco deal may extend drug patents to 30 years. Ahmad K Lancet; 2003 Dec; 362(9399):1904. PubMed ID: 14672079 [No Abstract] [Full Text] [Related]
15. Intellectual property and access to ART: unwise choice of terminology. Stallman R PLoS Med; 2006 Nov; 3(11):e509; author reply e510. PubMed ID: 17132062 [No Abstract] [Full Text] [Related]
16. Clearing a path through the patent thicket. Holman C Cell; 2006 May; 125(4):629-33. PubMed ID: 16713553 [TBL] [Abstract][Full Text] [Related]
17. The new patent law may accelerate innovation in ophthalmology. Higginbotham EJ; Upadhyay A; Egbuonu-Davis L JAMA Ophthalmol; 2014 Feb; 132(2):137-8. PubMed ID: 24310429 [No Abstract] [Full Text] [Related]
18. Patents & public health: international trade obligations and domestic policy development. Amani B Health Law Can; 2002 Feb; 22(3):76-84. PubMed ID: 11915591 [No Abstract] [Full Text] [Related]
19. Patents and innovation in cancer therapeutics: lessons from CellPro. Bar-Shalom A; Cook-Deegan R Milbank Q; 2002; 80(4):637-76, iii-iv. PubMed ID: 12532643 [TBL] [Abstract][Full Text] [Related]
20. Impact of economic, regulatory, and patent policies on innovation in cancer chemoprevention. Grabowski HG; Moe JL Cancer Prev Res (Phila); 2008 Jul; 1(2):84-90. PubMed ID: 19138940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]